These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 14762037)
1. C-reactive protein and the risk of incident colorectal cancer. Erlinger TP; Platz EA; Rifai N; Helzlsouer KJ JAMA; 2004 Feb; 291(5):585-90. PubMed ID: 14762037 [TBL] [Abstract][Full Text] [Related]
2. Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study. Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S; Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):690-5. PubMed ID: 16614110 [TBL] [Abstract][Full Text] [Related]
3. C-reactive protein concentrations and subsequent ovarian cancer risk. McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Pollak M; Tao Y; Helzlsouer KJ Obstet Gynecol; 2007 Apr; 109(4):933-41. PubMed ID: 17400857 [TBL] [Abstract][Full Text] [Related]
4. A prospective study of serum C-reactive protein and colorectal cancer risk in men. Gunter MJ; Stolzenberg-Solomon R; Cross AJ; Leitzmann MF; Weinstein S; Wood RJ; Virtamo J; Taylor PR; Albanes D; Sinha R Cancer Res; 2006 Feb; 66(4):2483-7. PubMed ID: 16489056 [TBL] [Abstract][Full Text] [Related]
5. C-reactive protein and colorectal adenoma in the CLUE II cohort. Tsilidis KK; Erlinger TP; Rifai N; Hoffman S; Hoffman-Bolton J; Helzlsouer KJ; Platz EA Cancer Causes Control; 2008 Aug; 19(6):559-67. PubMed ID: 18214695 [TBL] [Abstract][Full Text] [Related]
6. C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Zhang SM; Buring JE; Lee IM; Cook NR; Ridker PM Ann Intern Med; 2005 Mar; 142(6):425-32. PubMed ID: 15767620 [TBL] [Abstract][Full Text] [Related]
7. Association between C-reactive protein and age-related macular degeneration. Seddon JM; Gensler G; Milton RC; Klein ML; Rifai N JAMA; 2004 Feb; 291(6):704-10. PubMed ID: 14871913 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 and risk of colorectal cancer: results from the CLUE II cohort and a meta-analysis of prospective studies. Kakourou A; Koutsioumpa C; Lopez DS; Hoffman-Bolton J; Bradwin G; Rifai N; Helzlsouer KJ; Platz EA; Tsilidis KK Cancer Causes Control; 2015 Oct; 26(10):1449-60. PubMed ID: 26220152 [TBL] [Abstract][Full Text] [Related]
9. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. Siemes C; Visser LE; Coebergh JW; Splinter TA; Witteman JC; Uitterlinden AG; Hofman A; Pols HA; Stricker BH J Clin Oncol; 2006 Nov; 24(33):5216-22. PubMed ID: 17114654 [TBL] [Abstract][Full Text] [Related]
10. Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women. Wei EK; Giovannucci E; Selhub J; Fuchs CS; Hankinson SE; Ma J J Natl Cancer Inst; 2005 May; 97(9):684-92. PubMed ID: 15870439 [TBL] [Abstract][Full Text] [Related]
11. High-sensitive C-reactive protein and risk of incident type 2 diabetes: a case-control study nested within the Singapore Chinese Health Study. Pan A; Wang Y; Yuan JM; Koh WP BMC Endocr Disord; 2017 Feb; 17(1):8. PubMed ID: 28178951 [TBL] [Abstract][Full Text] [Related]
12. Oral contraceptive use and risk of colorectal cancer. Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422 [TBL] [Abstract][Full Text] [Related]
13. Plasma vitamin B12 concentrations and the risk of colorectal cancer: a nested case-referent study. Dahlin AM; Van Guelpen B; Hultdin J; Johansson I; Hallmans G; Palmqvist R Int J Cancer; 2008 May; 122(9):2057-61. PubMed ID: 18092327 [TBL] [Abstract][Full Text] [Related]
14. White blood cell count and the risk of colon cancer. Lee YJ; Lee HR; Nam CM; Hwang UK; Jee SH Yonsei Med J; 2006 Oct; 47(5):646-56. PubMed ID: 17066508 [TBL] [Abstract][Full Text] [Related]
15. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. Despriet DD; Klaver CC; Witteman JC; Bergen AA; Kardys I; de Maat MP; Boekhoorn SS; Vingerling JR; Hofman A; Oostra BA; Uitterlinden AG; Stijnen T; van Duijn CM; de Jong PT JAMA; 2006 Jul; 296(3):301-9. PubMed ID: 16849663 [TBL] [Abstract][Full Text] [Related]
16. Elevation of C-reactive protein level is associated with synchronous and advanced colorectal neoplasm in men. Chiu HM; Lin JT; Chen TH; Lee YC; Chiu YH; Liang JT; Shun CT; Wu MS Am J Gastroenterol; 2008 Sep; 103(9):2317-25. PubMed ID: 18844617 [TBL] [Abstract][Full Text] [Related]
17. Plasma enterolignan concentrations and colorectal cancer risk in a nested case-control study. Kuijsten A; Hollman PC; Boshuizen HC; Buijsman MN; van 't Veer P; Kok FJ; Arts IC; Bueno-de-Mesquita HB Am J Epidemiol; 2008 Mar; 167(6):734-42. PubMed ID: 18192676 [TBL] [Abstract][Full Text] [Related]
19. Plasma Inflammatory Markers and Risk of Advanced Colorectal Adenoma in Women. Song M; Mehta RS; Wu K; Fuchs CS; Ogino S; Giovannucci EL; Chan AT Cancer Prev Res (Phila); 2016 Jan; 9(1):27-34. PubMed ID: 26511487 [TBL] [Abstract][Full Text] [Related]
20. Baseline serum C-reactive protein and death from colorectal cancer in the NHANES III cohort. Swede H; Hajduk AM; Sharma J; Rawal S; Rasool H; Vella AT; Tobet RE; Stevens RG Int J Cancer; 2014 Apr; 134(8):1862-70. PubMed ID: 24122448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]